ArticleCell reports2026

Optineurin modulates mTORC2/AKT/STAT3 signaling to control MHC class II expression and adaptive immunity against HSV-1.

Rashmi Kadam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.